CSIMarket
 


Thorne Healthtech Inc   (THRN)
Other Ticker:  
 

Thorne Healthtech Inc 's Quick Ratio

THRN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2023, Quick Ratio fell to 0.3 a new company low.

Within Major Pharmaceutical Preparations industry 450 other companies have achieved higher Quick Ratio than Thorne Healthtech Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 2659 to 2910.

Explain Quick Ratio?
How much Cash & cash equivalents THRN´s has?
What are THRN´s Current Liabilities?


THRN Quick Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Change 62.71 % 17.88 % 53.71 % -38.2 % -
Y / Y Cash & cash equivalent Change -38.54 % -64.78 % -29.5 % -70.65 % -
Quick Ratio MRQ 0.3 0.35 0.91 0.78 0.8
THRN's Total Ranking # 2910 # 2659 # 1925 # 2279 # 1876
Seq. Current Liabilities Change 76.28 % -19.35 % 36.56 % -16.19 % 27.72 %
Seq. Cash & cash equivalent Change 54.53 % -69.29 % 60.05 % -19.06 % -11.44 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 451
Healthcare Sector # 887
Overall Market # 2910


Quick Ratio Statistics
High Average Low
1.99 0.99 0.3
(Dec 31 2021)   (Jun 30 2023)




Financial Statements
Thorne Healthtech Inc 's Current Liabilities $ 56 Millions Visit THRN's Balance sheet
Thorne Healthtech Inc 's Cash & cash equivalent $ 17 Millions Visit THRN's Balance sheet
Source of THRN's Sales Visit THRN's Sales by Geography


Cumulative Thorne Healthtech Inc 's Quick Ratio

THRN's Quick Ratio for the trailling 12 Months

THRN Quick Ratio

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities TTM Growth 62.71 % 17.88 % 53.71 % -38.2 % -
Y / Y Cash & cash equivalent TTM Growth -38.54 % -64.78 % -29.5 % -70.65 % -
Quick Ratio TTM 0.55 0.72 0.9 1.14 1.39
Total Ranking TTM # 2530 # 4061 # 3684 # 1659 # 1869
Seq. Current Liabilities TTM Growth 76.28 % -19.35 % 36.56 % -16.19 % 27.72 %
Seq. Cash & cash equivalent TTM Growth 54.53 % -69.29 % 60.05 % -19.06 % -11.44 %


On the trailing twelve months basis Due to jump in Current Liabilities in the II Quarter 2023 to $56.25 millions, cumulative Quick Ratio decreased to 0.55 below the Thorne Healthtech Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 456 other companies have achieved higher Quick Ratio than Thorne Healthtech Inc . While Quick Ratio overall ranking has improved so far to 2530, from total ranking during the twelve months ending first quarter 2023 at 4061.

Explain Quick Ratio?
How much Cash & cash equivalents THRN´s has?
What are THRN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 457
Healthcare Sector # 897
Within the Market # 2530


trailing twelve months Quick Ratio Statistics
High Average Low
1.39 1 0.55
(Jun 30 2022)   (Jun 30 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2023 MRQ Cash & cash equivalentJun 30 2023 MRQ Current Liabilities
Kineta Inc   0.83 $ 7.770  Millions$ 9.369  Millions
Tenx Keane Acquisition  0.81 $ 0.370  Millions$ 0.459  Millions
Cellectar Biosciences inc   0.81 $ 5.153  Millions$ 6.392  Millions
Maravai Lifesciences Holdings Inc   0.79 $ 580.176  Millions$ 730.376  Millions
Xencor Inc  0.78 $ 34.710  Millions$ 44.630  Millions
Blue Water Biotech Inc   0.76 $ 9.223  Millions$ 12.134  Millions
Applied Therapeutics inc   0.75 $ 35.616  Millions$ 47.188  Millions
Elite Pharmaceuticals Inc   0.75 $ 9.098  Millions$ 12.078  Millions
Vbi Vaccines Inc  0.75 $ 20.840  Millions$ 27.674  Millions
Collegium Pharmaceutical Inc   0.75 $ 325.470  Millions$ 435.058  Millions
Johnson and Johnson  0.74 $ 28,505.000  Millions$ 38,498.000  Millions
Intercept Pharmaceuticals inc   0.74 $ 137.505  Millions$ 187.022  Millions
Novabay Pharmaceuticals Inc   0.73 $ 4.414  Millions$ 6.066  Millions
Theratechnologies Inc   0.72 $ 34.097  Millions$ 47.294  Millions
Ptc Therapeutics inc   0.71 $ 337.943  Millions$ 476.342  Millions
Kazia Therapeutics Limited  0.69 $ 5.241  Millions$ 7.565  Millions
Cumberland Pharmaceuticals Inc  0.69 $ 18.249  Millions$ 26.638  Millions
Panbela Therapeutics Inc   0.68 $ 7.205  Millions$ 10.555  Millions
Fortress Biotech Inc   0.67 $ 86.772  Millions$ 128.583  Millions
Clever Leaves Holdings Inc   0.67 $ 5.077  Millions$ 7.562  Millions
Prophase Labs Inc   0.67 $ 9.104  Millions$ 13.675  Millions
Nrx Pharmaceuticals Inc   0.66 $ 14.969  Millions$ 22.617  Millions
Amphastar Pharmaceuticals Inc   0.66 $ 165.336  Millions$ 251.285  Millions
Sanofi  0.63 $ 10,193.120  Millions$ 16,068.640  Millions
Entrada Therapeutics Inc   0.63 $ 79.743  Millions$ 125.940  Millions
Perrigo Company Plc  0.63 $ 555.200  Millions$ 882.600  Millions
Benitec Biopharma Inc   0.63 $ 2.502  Millions$ 3.978  Millions
Alzamend Neuro Inc   0.62 $ 1.695  Millions$ 2.741  Millions
Lucy Scientific Discovery Inc   0.62 $ 1.674  Millions$ 2.710  Millions
Morphosys Ag  0.60 $ 177.520  Millions$ 296.027  Millions

Date modified: 2023-08-11T05:32:47+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com